Investor Presentation First Nine Months of 2023

20 Investor presentation First nine months of 2023 Novo Nordisk Corporate Strategy Diabetes Strengthen leadership by offering innovative medicines and driving patient outcomes Rare Disease Secure a leading position by leveraging full portfolio and expanding into adjacent areas Novo Nordisk Way Driving change to defeat serious chronic diseases Sustainable business Obesity Strengthen leadership through market development and by offering innovative medicines and driving patient outcomes Other Serious Chronic Diseases Establish presence by building competitive pipeline and scientific leadership Novo NordiskⓇ

View entire presentation